GT Apeiron Therapeutics

About:

GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology.

Website: https://www.apeiron-bio.com

Top Investors: GT Healthcare Capital Partners, Viva BioInnovator, Panacea Venture

Description:

GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology. The company develops breakthrough investigational medicines by harnessing the power of artificial intelligence, aiming to drastically increase efficiency throughout the drug discovery process.

Total Funding Amount:

$44.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2019-01-01

Founders:

Alan Au

Number of Employees:

11-50

Last Funding Date:

2022-03-29

IPO Status:

Private

© 2024 MyAiNote.com